Scott Rocklage is currently the managing partner at an institution known as 5 AM Ventures. He acquired this position in the year 2004, and he has done a lot to bring positive changes in the company. Scott joined the company in 2003 as a venture partner. Rockalage has worked in the healthcare management industry for more than 30 years, and this means that he has all the expertise and scientific background needed by 5 AM Ventures.
Rockledge is also respected because of his leadership skills, and this played a key role in acquiring the Federal Drug Administration approval for three drug applications. These include Omniscan, Cubicin, and Teslascan. At the moment, 5 AM Ventures is headquartered in San Francisco, and it has been very successful under the leadership of Scott Rocklage.
Before joining the healthcare company in the year 2003, Scott was working as the chief operating officer and chairman of an institution known as the Cubist Pharmaceuticals. The successful scientist was also the chief executive officer and president of Nycomed Salutar. In these positions, Scott was responsible for research and designs.
Rocklage is also believed to have worked as the chief executive officer at Amersham Health. While working as the co-president and chairman of Ilypsa, Rocklage is thought to have introduced many successful projects that led to the growth of the company. This background exposed him to a lot of knowledge in science, healthcare and leadership roles, making him one of the most efficient leaders and strategists in the healthcare and pharmaceutical industry.
Scott went for his education at the University of California where he acquired a bachelor’s degree in chemistry. The successful scientist went for his Doctor of Philosophy in Chemistry from the prestigious Massachusetts Institute of Technology. While doing his Ph.D. in MIT, Scott was able to conduct research in Richard R Schrock laboratory successfully. Today, Scott is recognized in the United States for being an inventor or co-inventor of over thirty patents. The scientist is believed to have published more than one hundred articles too in the healthcare industry. The publications have done very well on different platforms, and students in learning institutions use them.